Skip to main content
. Author manuscript; available in PMC: 2013 Aug 7.
Published in final edited form as: Am J Gastroenterol. 2008 Sep 4;103(10):2432–2442. doi: 10.1111/j.1572-0241.2008.02117.x

Table 3.

Results of Base Analysis

Percentage Willing to Take the Drug Under Base Conditions
All F M
Results stratified by gender
Number of subjects (N) 100 28 72
 Celecoxib 15.0% 14.3% 15.3%
 Aspirin 76.0% 82.1% 73.6%

All HGD No HGD

Results stratified by history of HGD
Number of subjects (N) 100 45 55
 Celecoxib 15.0% 20.0% 10.9%
 Aspirin 76.0% 68.9% 81.8%

HGD = history of high-grade dysplasia.

P < 0.0001; difference in percentage willing to take the two drugs.